A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients.

Ups J Med Sci · 2022 · PMC9602199 · PMID 36337280

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A major and highly significant difference in anti-S response was found between 7 and 15 weeks after dose two and 3 months after the third vaccine dose.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.